Welltower Inc is projected to report Q3 2026 revenue of $3.73 billion and Normalized FFO of $1.64 per share, with the stock currently trading at $240.64 against an average analyst price target of $260.68.
The primary focus for investors remains the Same-Store Net Operating Income (SSNOI) growth within the Senior Housing Operating Portfolio (SHOP), which analysts expect to maintain its robust double-digit trajectory.
The healthcare REIT continues to benefit from a favorable supply-demand imbalance in senior housing and aggressive occupancy gains across its core U.S. and U.K. markets. Market participants will also look for updates on the company’s massive $11 billion-plus disposition program and its impact on long-term FFO growth projections.